Brain stimulation therapies for treatment-resistant depression;Tecniche di stimolazione cerebrale nel trattamento della depressione resistente

Rivista di Psichiatria

Volumn 48, Issue 3, 2013, Pages 175-181

  Vitalucci, Alberto ^a   Coppola, Isabella ^a   Mirra, Marta ^a   Maina, Giuseppe ^a   Bogetto, Filippo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Brain stimulation therapies; Treatment resistant depression

Indexed keywords

BRAIN DEPTH STIMULATION; ELECTROCONVULSIVE THERAPY; EPIDURAL CORTICAL STIMULATION; EXPERIMENTAL THERAPY; HUMAN; NERVE STIMULATION; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION;

DEEP BRAIN STIMULATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 84879006310     PISSN: 00356484     EISSN: 20382502     Source Type: Journal    
DOI: 10.1708/1292.14285     Document Type: Review

References (72)

1. Wijeratne C, Sachdev P. Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry 2008; 42: 751-62.
2. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63: 963-71. (Pubitemid 35388053)
3. Fostick L, Silberman A, Beckman M, Spivak B, Amital D. The economic impact of depression: resistance or severity? Eur Neuropsychopharmacol 2010; 20: 671-5.
4. Nemeroff CB. Prevalence and management of treatment-resist - ant depression. J Clin Psychiatry 2007; 68 (suppl 8): 17-25. (Pubitemid 47184567)
5. Sackheim HA. The definition and meaning of treatment-resist - ant depression. J Clin Psychiatry 2001; 62 (suppl 16): 10-7.
6. Trivedi MH, Rush AJ, Wisniewski SR, et al.; STAR D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40. (Pubitemid 43050100)
7. Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord 2009; 117 (suppl 1): S44-S53.
8. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993; 328: 839-46. (Pubitemid 23084338)
9. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425-34. (Pubitemid 30257256)
10. The UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799-808.
11. Stoppe A, Louza M, Rosa M, Gil G, Rigonatti S. Fixed high-dose electroconvulsive therapy in the elderly with depression: a double blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. J ECT 2006; 22: 92-9. (Pubitemid 44491106)
12. Eschweiler GW, Vonthein R, Bode R, et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomized controlled trial in pharmaco-resistant major depression. J Affect Disord 2007; 101: 149-57. (Pubitemid 46879927)
13. Shapira B, Tubi N, Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: role of treatment schedule. J ECT 2000; 169: 97-109.
14. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244-53. (Pubitemid 33131305)
15. Kho KH, Fink M, Rummans TA, et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003; 19: 139-47. (Pubitemid 37087760)
16. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004; 20: 13-20. (Pubitemid 38488810)
17. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985-92. (Pubitemid 26264697)
18. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, et al. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 2006; 16: 620-4. (Pubitemid 44781079)
19. Husain MM, McClintock SM, Rush AJ, Knapp RG. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 2008; 69: 406-11. (Pubitemid 351549393)
20. Grunhaus L, Schreiber S, Dolberg OT, Hirshman S, Dannon PN. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord 2002; 4 (suppl 1): 91-3.
21. Kellner CH, Fink M, Knapp R, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 2005; 162: 977-82. (Pubitemid 40676212)
22. Kramer BA. Use of ECT in California, revisited: 1984-1994. J ECT 1999; 15: 245-51.
23. Wijeratne C, Halliday GS, Lyndon RW. The present status of electroconvulsive therapy: a systematic review. Med J Aust 1999; 171: 250-4. (Pubitemid 29429814)
24. Marano CM, Phatak P, Vemulapalli UR, et al. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 2007; 68: 512-7. (Pubitemid 46663032)
25. George MS, Bohning DE, Lorberbau JP, et al. Overview of transcranial magnetic stimulation: history, mechanisms, physics and safety. In: George MS, Belmaker RH (eds). Transcranial magnetic stimulation in clinical psychiatry. Washington: American Psychiatric Press, 2007: pp. 1-38.
26. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006; 117: 2584-96. (Pubitemid 44781313)
27. Fitzgerald PB, Hoy K, McQueen S, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment resistant depression. Neuropsychopharmacology 2009; 34: 1255-62.
28. O'Reardon JP, Solvasonm HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-16. (Pubitemid 350060890)
29. Loo CK, Mitchell PB, McFarquhar TF, Malhi GS, Sachdev S. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression. Psychol Med 2006; 37: 341-9.
30. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2008; 39: 65-75.
31. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. Rev Psychiatr Neurosci 2005; 30: 83-90. (Pubitemid 40769298)
32. Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Br J Psychiatry 2003; 182: 480-91. (Pubitemid 36649193)
33. Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 2010; 167: 323-8.
34. Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systemic review and meta-analysis. Can J Psychiatry 2008; 53: 621-31.
35. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66: 1524-8. (Pubitemid 43068690)
36. Bretlau LG, Lunde M, Lindberg L, Unden M, Dissing S, Bech P. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomized, sham-controlled trial. Pharmacopsychiatry 2008; 41: 41-7. (Pubitemid 351427521)
37. Rossini D, Magri L, Lucca A, Giordani S, Smeraldi E, Zanardi R. Does rTMS fasten the response to escitalopram, sertraline or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J Clin Psychiatry 2005; 66: 1569-75. (Pubitemid 43068697)
38. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34: 522-34.
39. Fitzgerald PB, Daskalakis ZJ. The use of repetitive transcranial magnetic stimulation and vagal nerve stimulation in the treatment of depression. Curr Opin Psychiatry 2008; 21: 25-9. (Pubitemid 351339804)
40. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003; 160: 835-45. (Pubitemid 41079567)
41. Fregni F, Ono CR, Santos CM, et al. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 2006; 66: 1629-37. (Pubitemid 43964613)
42. Jorge Re, Moser DJ, Action L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008; 65: 268-76. (Pubitemid 351342443)
43. Avery DH, Holtzheimer PE, Fawaz W, et al. Transcranial magnetic stimulation reduces pain in patients with major depression. J Nerv Ment Dis 2007; 195: 378-81. (Pubitemid 46763238)
44. Zanardi R, Magri L, Rossini D, et al. Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Eur Neuropsychopharmacol 2007; 17: 651-7. (Pubitemid 47268754)
45. Zanardini R, Gazzoli A, Ventriglia M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord 2006; 91: 83-6. (Pubitemid 43254643)
46. Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation [letter]. Clin Neurophysiol 2000; 112: 720.
47. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008; 11: 131-47.
48. Moser DJ, Jorge RE, Manes F, Paradiso S, Benjamin ML, Robinson RG. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 2002; 58: 1288-90. (Pubitemid 34411879)
49. Nahas Z, Kozel FA, Molnar C, et al. Methods of administering transcranial magnetic stimulation. In: George MS, Belmaker RH (eds). Transcranial Magnetic Stimulation in Clinical Psychiatry. Washington: American Psychiatric Press, 2008.
50. Rado J, Janicak PG. Vagus nerve stimulation for severe depression. J Psychosoc Nurs Ment Health Serv 2007; 45: 43-51.
51. Maina G, Albert U, Bertetto N, Pessina E, Vitalucci A, Bogetto F. La stimolazione del nervo vago nel trattamento della depressione resistente (Vagus nerve stimulation for treatment-resistant depression). Giornale Italiano di Psicopatologia 2009; 15: 151-62.
52. Pardo JV, Sheikh SA, Schwindt GC, et al. Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glicose metabolism. Neuroimage 2008; 42: 879-89.
53. Nemeroff CB, Mayberg HS, Krahl SE, et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanism. Neuropsychopharmacology 2006; 31: 1345-55.
54. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000; 47: 276-86. (Pubitemid 30109240)
55. Sackeim HA, Rish AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25: 713-28. (Pubitemid 32995954)
56. Corcoran CD, Thomas P, Philips J, O'Keane V. Vagus nerve stimulation in chronic treatment-resistant depression: preliminary findings of an open-label study. Br J Psychiatry 2006; 189: 282-3. (Pubitemid 44343477)
57. Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008; 38: 651-61. (Pubitemid 351483238)
58. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58: 347-54. (Pubitemid 41219702)
59. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002; 51: 280-7. (Pubitemid 34214993)
60. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005; 66: 1097-104. (Pubitemid 41442274)
61. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005; 58: 355-63. (Pubitemid 41219703)
62. Niermberg AA, Alpert JE, Gardner-Shuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry 2008; 64: 455-60.
63. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005; 58: 364-73. (Pubitemid 41219704)
64. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008; 64: 461-7.
65. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-60. (Pubitemid 40320700)
66. Neimat JS, Hamani C, Giacobbe P, et al. Neural stimulation successfully treats depression in patient with prior ablative cingulotomy. Am J Psychiatry 2008; 165: 687-93. (Pubitemid 351810536)
67. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33: 368-77. (Pubitemid 350243349)
68. Malone DA Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009; 65: 267-75.
69. Quante A, Luborzewski A, Brakemeier EL, Merkl A, Danker-Hopfe H, Bajbouj M. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. J Psychiatr Res 2011; 45: 174-8.
70. Holtzheimer PE, McDonald WM, Mufti M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010; 27: 960-3.
71. Hajcak G, Anderson BS, Arana A, et al. Dorsolateral prefrontal cortex stimulation modulates electrocortical measures of visual attention: evidence from direct bilateral epidural cortical stimulation in treatment-resistant mood disorder. Neuroscience 2010; 170: 281-8.
72. Nahas Z, Anderson BS, Borckardt J, et al. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry 2010; 67: 101-9.